Deutsche Bank’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-30
Closed -$1K 4507
2020
Q1
$1K Sell
30
-24
-44% -$1.82K ﹤0.01% 4267
2019
Q4
$4K Hold
54
﹤0.01% 4718
2019
Q3
$3K Buy
+54
New +$5.51K ﹤0.01% 4753

Other funds holding ASLN

Deutsche Bank's ASLN Position: Q2 2020 in Review

Deutsche Bank sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2020, closing a stake of 30 shares — an estimated $1K sold.

Deutsche Bank first reported a position in ASLN in Q3 2019 and held it in 3 quarters. The position peaked at $4K in Q4 2019. 9 funds tracked by Wall St. Rank hold ASLN as of Q2 2020.

  • Deutsche Bank reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Deutsche Bank sold 30 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2020, an estimated $1K.
  • Deutsche Bank first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2019 and held it in 3 quarters.
  • Deutsche Bank's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $4K in Q4 2019.
  • 9 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2020.

Based on Deutsche Bank's 13F filing for Q2 2020, filed 13 Aug 2020.